| Avisesh Sahgal, MD | |
|
12005 Sunrise Valley Drive, Suite 120, Reston, VA 20191-3469 | |
| (571) 375-7174 | |
| (571) 375-7177 |
| Full Name | Avisesh Sahgal |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 29 Years |
| Location | 12005 Sunrise Valley Drive, Suite 120, Reston, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902862261 | NPI | - | NPPES |
| 1902862261 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 0101234860 (Virginia) | Secondary |
| 208600000X | Surgery | 0101234860 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reston Hospital Center | Reston, VA | Hospital |
| Inova Loudoun Hospital | Leesburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Loudoun Medical Group, Pc | 0042119661 | 280 |
| Loudoun Medical Group, Pc | 0042119661 | 280 |
News Archive
Oncolytics Biotech Inc. today announced completion of patient enrollment in a two-arm randomized phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer (OSU-10045).
The U.S. government continues to lay the groundwork for efforts under the U.S. Global Health Initiative (GHI), announcing the first round of "GHI Plus" countries, as well as the program's governance structure. GHI is a six-year, $63 billion initiative to help partner countries improve measurable health outcomes by strengthening health systems and building upon proven results. It places a particular focus on improving the health of women, newborns and children.
The bite from a brown recluse spider (Loxosceles) can cause skin necrosis, renal failure, and even death. A new ointment is being tested in Brazil, however. Its effects have already been proven in tests conducted in cell cultures and animal models.
A unique vaccine to protect against COVID-19 begins clinical testing Tuesday, 6 April, at the Walter Reed Army Institute of Research (WRAIR), part of the U.S. Army Medical Research and Development Command.
› Verified 3 days ago
| Entity Name | Loudoun Medical Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407908817 PECOS PAC ID: 0042119661 Enrollment ID: O20040102000616 |
News Archive
Oncolytics Biotech Inc. today announced completion of patient enrollment in a two-arm randomized phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer (OSU-10045).
The U.S. government continues to lay the groundwork for efforts under the U.S. Global Health Initiative (GHI), announcing the first round of "GHI Plus" countries, as well as the program's governance structure. GHI is a six-year, $63 billion initiative to help partner countries improve measurable health outcomes by strengthening health systems and building upon proven results. It places a particular focus on improving the health of women, newborns and children.
The bite from a brown recluse spider (Loxosceles) can cause skin necrosis, renal failure, and even death. A new ointment is being tested in Brazil, however. Its effects have already been proven in tests conducted in cell cultures and animal models.
A unique vaccine to protect against COVID-19 begins clinical testing Tuesday, 6 April, at the Walter Reed Army Institute of Research (WRAIR), part of the U.S. Army Medical Research and Development Command.
› Verified 3 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
Oncolytics Biotech Inc. today announced completion of patient enrollment in a two-arm randomized phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer (OSU-10045).
The U.S. government continues to lay the groundwork for efforts under the U.S. Global Health Initiative (GHI), announcing the first round of "GHI Plus" countries, as well as the program's governance structure. GHI is a six-year, $63 billion initiative to help partner countries improve measurable health outcomes by strengthening health systems and building upon proven results. It places a particular focus on improving the health of women, newborns and children.
The bite from a brown recluse spider (Loxosceles) can cause skin necrosis, renal failure, and even death. A new ointment is being tested in Brazil, however. Its effects have already been proven in tests conducted in cell cultures and animal models.
A unique vaccine to protect against COVID-19 begins clinical testing Tuesday, 6 April, at the Walter Reed Army Institute of Research (WRAIR), part of the U.S. Army Medical Research and Development Command.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Avisesh Sahgal, MD 224-d Cornwall Street, Nw, Suite 403, Ste 403, Leesburg, VA 20176-2704 Ph: (703) 737-6010 | Avisesh Sahgal, MD 12005 Sunrise Valley Drive, Suite 120, Reston, VA 20191-3469 Ph: (571) 375-7174 |
News Archive
Oncolytics Biotech Inc. today announced completion of patient enrollment in a two-arm randomized phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer (OSU-10045).
The U.S. government continues to lay the groundwork for efforts under the U.S. Global Health Initiative (GHI), announcing the first round of "GHI Plus" countries, as well as the program's governance structure. GHI is a six-year, $63 billion initiative to help partner countries improve measurable health outcomes by strengthening health systems and building upon proven results. It places a particular focus on improving the health of women, newborns and children.
The bite from a brown recluse spider (Loxosceles) can cause skin necrosis, renal failure, and even death. A new ointment is being tested in Brazil, however. Its effects have already been proven in tests conducted in cell cultures and animal models.
A unique vaccine to protect against COVID-19 begins clinical testing Tuesday, 6 April, at the Walter Reed Army Institute of Research (WRAIR), part of the U.S. Army Medical Research and Development Command.
› Verified 3 days ago
Dr. Karim Sami Trad, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 Town Center Drive, Suite 218, Reston, VA 20190 Phone: 703-796-0370 Fax: 703-796-0373 | |
Dr. Elizabeth D Feldman, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1860 Town Center Dr Ste 460, Reston, VA 20190 Phone: 032-089-3957 Fax: 703-437-6549 | |
Dr. Bruce M Freedman, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 Town Center Dr, Ste 413, Reston, VA 20190 Phone: 703-790-5700 Fax: 703-827-8730 | |
Matthew A Fitzer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1850a Town Center Pkwy, Suite 301, Reston, VA 20190 Phone: 703-709-9701 Fax: 703-709-8084 | |
Dr. Timothy Roddy Shaver, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1860 Town Center Dr Ste 440, Reston, VA 20190 Phone: 571-554-8950 Fax: 571-554-8951 | |
Dr. Brett Allen Sachse, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1830 Town Center Dr, Suite 102, Reston, VA 20190 Phone: 571-512-5300 Fax: 571-699-0445 | |
Robert Stephen Podolsky, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 12005 Sunrise Valley Drive, Suite 120, Reston, VA 20191 Phone: 571-375-7174 Fax: 571-375-7177 |